When to Refer vs. Treat PMADs in Primary Care
Written by
Phoenix Health Editorial Team
Expert health information, double-checked for accuracy and written to be helpful.
Last updated
The Clinical Decision
Primary care providers, OBGYNs, and midwives increasingly manage mild psychiatric presentations within their practice, including mild depression and anxiety. This is appropriate and reflects integrated care principles. The question for PMAD presentations is where the line falls between conditions the generalist can manage and those that require perinatal mental health specialty care.
The answer depends on several factors: severity, diagnostic complexity, treatment modality, clinical response to initial treatment, and provider capacity. This article provides a practical framework for making that decision.
---
Conditions Appropriate for In-Practice Management
Mild-to-moderate postpartum depression with appropriate characteristics
A patient with an EPDS score of 10 to 14, functioning adequately in daily life, with good social support, no prior psychiatric history, and symptoms of less than 4 weeks duration may be appropriate for initial management in the primary care or OB setting if the provider is comfortable with:
- Brief supportive counseling and psychoeducation
- Prescribing or managing an SSRI (if the provider is a prescribing clinician with SSRI experience)
- Close monitoring at 2 to 4 week intervals
- Clear criteria for escalating to specialty referral if the patient does not respond
Watchful waiting alone -- without active clinical management -- is not appropriate for this presentation. If the practice cannot provide active management, refer.
Perinatal adjustment disorder
Adjustment disorder with anxious or depressed mood in response to identifiable perinatal stressors (obstetric complications, relationship conflict, infant health issues) is within the clinical scope of a primary care or OB practice that can provide brief supportive counseling, psychoeducation, and close monitoring.
---
Conditions That Require Specialty Referral
Moderate-to-severe postpartum depression (EPDS 15 and above)
At this severity, the patient is unlikely to respond to brief psychoeducation and supportive visits. Evidence-based treatment at this level requires structured therapy (CBT, IPT) that most OBs and PCPs cannot provide within the scope of a routine visit, and/or pharmacological management with specialty pharmacology knowledge.
Refer.
Any safety concern
Active suicidal ideation, passive ideation with prior attempts, infanticidal ideation, or any situation where the provider is concerned about the patient's safety requires:
- Immediate safety assessment
- Referral to a perinatal mental health provider or psychiatric consultation, same-day
- If the patient cannot contract for safety: emergency evaluation
Do not manage acute safety concerns in a general practice setting without psychiatric consultation.
Postpartum OCD
OCD requires ERP (Exposure and Response Prevention) therapy delivered by a therapist specifically trained in OCD. This is a highly specialized modality. Prescribing an SSRI is appropriate first-line pharmacological management that the OB or PCP can initiate. But ERP therapy should be delivered by a specialist. Refer for therapy while potentially managing pharmacology in partnership with the specialist.
Postpartum psychosis
Postpartum psychosis is a psychiatric emergency. Refer immediately. Hospitalization is typically indicated. This presentation should never be managed in a primary care setting without immediate psychiatric involvement.
Bipolar disorder, peripartum episode
Perinatal mood episodes in patients with known or suspected bipolar disorder require psychiatric management, not primary care management. The pharmacological considerations (mood stabilizers in pregnancy and breastfeeding, avoidance of antidepressants without mood stabilizer coverage) are outside the scope of most general practitioners.
PTSD related to birth trauma or prior trauma
Trauma-focused treatment requires a therapist trained in evidence-based trauma modalities: Prolonged Exposure (PE), EMDR, or CPT. These are specialty skills. The OB or PCP can appropriately screen for PTSD symptoms and provide normalizing psychoeducation. Treatment should be referred.
Treatment-resistant presentation
A patient who has been on an adequate SSRI trial (6 to 8 weeks at therapeutic dose) without meaningful response, or who has relapsed following an initial response, requires psychiatric consultation and a more complex treatment planning process. This is not a primary care management situation.
Complex diagnostic picture
Patients with comorbid conditions -- PMAD plus prior substance use, PMAD plus chronic pain, PMAD plus eating disorder, PMAD plus complex trauma history -- require specialty mental health management.
---
The Role of SSRI Prescribing in PMAD Management
Many OBGYNs and PCPs are comfortable prescribing SSRIs for mild-to-moderate postpartum depression. This is clinically appropriate in the right circumstances, and there is significant value in having the reproductive health provider initiate treatment when there will be a delay to specialty care.
When OB/PCP SSRI prescribing is appropriate
- Mild-to-moderate postpartum depression (EPDS 10 to 14)
- No prior bipolar disorder (antidepressants alone can precipitate manic episodes)
- No significant safety concern
- Patient is in agreement with pharmacological treatment
- Provider has capacity to monitor and adjust at 2 to 4 week intervals
- Clear plan for referral if patient does not respond
First-line SSRI selection in perinatal settings
Sertraline and escitalopram have the most robust safety data in pregnancy and breastfeeding and are the standard first-line agents in most perinatal guidelines.
- Sertraline (50 mg starting dose, titrate to 100 to 200 mg): Preferred first-line for most perinatal patients. Lowest relative infant dose in breastfed infants among commonly prescribed SSRIs.
- Escitalopram (10 mg starting dose, titrate to 20 mg): Well-tolerated; low absolute infant dose via breast milk.
- Fluoxetine: Long half-life increases accumulation in breastfed infants; generally avoided as first-line postpartum but used when patient has prior response.
For complete prescribing guidance including breastfeeding-specific data, see LactMed (NIH) and MotherToBaby.
When to transfer pharmacological management to a prescribing specialist
- Patient fails first-line SSRI
- Augmentation strategy is being considered
- Patient has comorbid bipolar, psychosis, or complex history
- Patient is requesting or requiring an agent with less familiar perinatal safety profile
---
Communicating the Referral Decision to Patients
Patients sometimes interpret a referral as the provider abandoning their care. The framing matters.
For patients being referred for therapy: "I'm referring you to a therapist who specializes in what you're going through. She works specifically with new parents, which means the treatment will be tailored to your exact situation. I will continue to see you for your regular care -- this is adding specialized support, not replacing what we do here."
For patients being referred because symptoms are more severe: "The level of support you need right now is beyond what I can provide in a visit with you. I'm sending you to someone who can see you regularly and give your mental health the dedicated attention it deserves. That is the right care for what you're experiencing."
For patients where the provider is managing medication and referring for therapy: "I'm going to start you on a medication today, and I also want you to see a therapist because the research shows that medication plus therapy works better than either one alone. The therapist I'm referring you to specializes in postpartum patients and can work with you on what's triggering the depression and anxiety."
---
Documentation
When making a referral decision -- whether to treat or to refer -- document the clinical rationale. The chart entry should include:
- EPDS score
- Clinical severity assessment
- Decision: manage in-practice OR refer
- If referring: to whom, with what urgency, using what mechanism
- If managing in-practice: treatment plan, monitoring frequency, and criteria for escalating to referral
This documentation is clinically protective and enables continuity if the patient transitions to another provider.
For the specific steps of making a warm referral and tracking follow-through, see our article on building a PMAD referral pathway in an OB practice.
Frequently Asked Questions
PCPs and OBGYNs with prescribing confidence can appropriately initiate SSRI therapy for mild to moderate PPD (PHQ-9 10 to 19, EPDS 10 to 18) in patients without significant psychiatric history, active suicidality, or psychotic features. First-line agents with the best perinatal safety and efficacy data are sertraline and escitalopram. Referral to psychiatry is appropriate for: severe presentations (PHQ-9 20+), treatment-resistant cases (inadequate response after 6 to 8 weeks at therapeutic dose), bipolar spectrum presentation, active suicidal ideation with plan, psychotic features, or a history of postpartum psychosis. Referral to therapy (CBT, IPT) is appropriate for all presentations, regardless of whether medication is initiated.
Document the positive screen, the clinical discussion, and the patient's decision clearly in the chart. This documentation is important both for continuity of care and for liability protection. For patients who decline referral, explore the barrier specifically: if cost is the issue, telehealth options and sliding-scale practices are relevant; if stigma is the issue, framing therapy as skills training rather than mental health treatment reduces resistance for some patients; if skepticism is the issue, motivational interviewing techniques applied in a 5-minute office visit can shift readiness to change. Set a defined follow-up interval (2 to 4 weeks) and re-screen at that visit. Patients who decline at first positive screen often accept referral after 1 to 2 follow-up conversations.
The evidence base consistently supports combined treatment (medication plus psychotherapy) as more effective than either modality alone for moderate to severe PPD. ACOG guidance recommends psychotherapy as a first-line treatment for mild to moderate PPD and as an adjunct for all medication-treated cases where the patient is willing and able to access it. Patients with a history of trauma (which is highly prevalent in perinatal populations), significant relationship distress, or attachment concerns particularly benefit from concurrent IPT or trauma-focused CBT. Medication-only management is clinically appropriate as a pragmatic choice when access to therapy is genuinely unavailable, but it should be documented as a limitation rather than a preferred clinical approach. Telehealth has significantly expanded therapy access in most markets.
Ready to take the next step?
Our PMH-C certified therapists specialize in exactly this β and most clients are seen within a week.